𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Blastic phase of chronic myelogenous leukemia

✍ Scribed by Merat Karbasian Esfahani; Evelyn L. Morris; Janice P. Dutcher; Peter H. Wiernik

Book ID
107531939
Publisher
Springer
Year
2006
Tongue
English
Weight
478 KB
Volume
7
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sudden onset of the blastic phase of chr
Sudden onset of the blastic phase of chronic myelogenous leukemia : Patterns and implications
✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Deborah Thomas; St πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

## Abstract ## BACKGROUND Therapeutic options in Philadelphia chromosome‐positive chronic myelogenous leukemia (Ph‐positive CML) in chronic phase include allogeneic stem cell transplantation (SCT) and treatments other than allogeneic SCT. The choice of therapy often depends on the mortality risk o

A Phase I–II trial of escalating doses o
A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia
✍ Charles A. Koller; Hagop M. Kantarjian; Eric J. Feldman; Susan O'Brien; Mary Bet πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

## BACKGROUND. Cytarabine is an essential drug for inducing remission of acute myelogenous leukemia, and it is also one the most effective drugs used as salvage therapy for patients with all types of relapsed acute leukemia. Nevertheless, there is considerable room for improvement in the treatment